Zurich Cantonal Bank’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.52M Buy
46,786
+10,009
+27% +$322K ﹤0.01% 1187
2025
Q4
$1.29M Buy
36,777
+968
+3% +$34.3K ﹤0.01% 1197
2025
Q3
$941K Buy
35,809
+3,264
+10% +$97.4K ﹤0.01% 1325
2025
Q2
$862K Buy
32,545
+2,099
+7% +$55.3K ﹤0.01% 1319
2025
Q1
$735K Buy
30,446
+3,611
+13% +$114K ﹤0.01% 1366
2024
Q4
$1.08M Buy
26,835
+4,012
+18% +$229K ﹤0.01% 1145
2024
Q3
$1.44M Buy
22,823
+646
+3% +$37.9K ﹤0.01% 938
2024
Q2
$1.18M Buy
22,177
+3,755
+20% +$246K ﹤0.01% 988
2024
Q1
$1.51M Sell
18,422
-1,915
-9% -$85.2K 0.01% 862
2023
Q4
$378K Buy
20,337
+3,698
+22% +$48.4K ﹤0.01% 1692
2023
Q3
$184K Buy
16,639
+4,136
+33% +$59.2K ﹤0.01% 2019
2023
Q2
$203K Buy
12,503
+3,420
+38% +$71.7K ﹤0.01% 1917
2023
Q1
$151K Buy
+9,083
New +$93.8K ﹤0.01% 2051
2022
Q2
Sell
-20,294
Closed -$61K 2933
2022
Q1
$61K Hold
20,294
﹤0.01% 2472
2021
Q4
$93K Buy
20,294
+12,145
+149% +$68.1K ﹤0.01% 2552
2021
Q3
$51K Hold
8,149
﹤0.01% 2607
2021
Q2
$49K Hold
8,149
﹤0.01% 2454
2021
Q1
$52K Hold
8,149
﹤0.01% 2375
2020
Q4
$46K Hold
8,149
﹤0.01% 2456
2020
Q3
$47K Hold
8,149
﹤0.01% 2270
2020
Q2
$59K Buy
8,149
+4,210
+107% +$28K ﹤0.01% 2161
2020
Q1
$18K Hold
3,939
﹤0.01% 2367
2019
Q4
$32K Hold
3,939
﹤0.01% 2357
2019
Q3
$27K Hold
3,939
﹤0.01% 2352
2019
Q2
$33K Hold
3,939
﹤0.01% 2286
2019
Q1
$39K Hold
3,939
﹤0.01% 2148
2018
Q4
$30K Buy
+3,939
New +$47.1K ﹤0.01% 2300

Other funds holding VKTX